220 related articles for article (PubMed ID: 27058425)
1. Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.
Song X; Shao Y; Gu W; Xu C; Mao H; Pei H; Jiang J
Oncotarget; 2016 Nov; 7(47):76523-76533. PubMed ID: 27058425
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
3. B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis.
Ye Z; Zheng Z; Li X; Zhu Y; Zhong Z; Peng L; Wu Y
Cell Physiol Biochem; 2016; 39(4):1568-80. PubMed ID: 27626927
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis.
Chen X; Tao L; Yuan C; Xiu D
Medicine (Baltimore); 2018 Mar; 97(12):e0088. PubMed ID: 29561406
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.
Meng Z; Wang F; Zhang Y; Li S; Wu H
Oncotarget; 2017 Sep; 8(40):68825-68836. PubMed ID: 28978159
[TBL] [Abstract][Full Text] [Related]
6. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
Perisanidis C; Psyrri A; Cohen EE; Engelmann J; Heinze G; Perisanidis B; Stift A; Filipits M; Kornek G; Nkenke E
Cancer Treat Rev; 2015 Dec; 41(10):960-70. PubMed ID: 26604093
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
9. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI
Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.
Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J
Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
[TBL] [Abstract][Full Text] [Related]
16. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
[TBL] [Abstract][Full Text] [Related]
18. Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis.
Hao B; Chen Z; Bi B; Yu M; Yao S; Feng Y; Yu Y; Pan L; Di D; Luo G; Zhang X
Oncotarget; 2018 Feb; 9(16):13088-13099. PubMed ID: 29560134
[TBL] [Abstract][Full Text] [Related]
19. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
[TBL] [Abstract][Full Text] [Related]
20. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
